#uegweek — Public Fediverse posts

7/#MondayNightIBD #UEGWeek
#CME🔗http://bit.ly/3XgqsH8

👇#IBDPoll 4⃣
🟢The U-ACHIEVE Maintenance study, looked @ pts w UC who responded to induction tx w upadacitinib @ 8wks

Which tx group led to greater clinical remission per adapted Mayo score at wk 52 compared to PBO?

6/#MondayNightIBD #UEGWeek
📲Tweet your❓for Mon LIVE Q&A @ 2p ET/ 7p GMT/ 8p CEST

👇#IBDPoll 3⃣
🟢Which of the following PRO questionnaires assesses pt fatigue using a 13-item tool & 5-point scale, where a ⬆️higher score indicates a better pt outcome?

5/#MondayNightIBD #UEGWeek
#CME🔗http://bit.ly/3XgqsH8
📲Tweet your❓for Mon LIVE Q&A

👇#IBDPoll 2⃣
🟢Which drug combo were given in the Ph2a VEGA study to show the potential of dual inhibition of IL-23 & TNFα to more effectively induce CR & remission in pts w mod-sev UC?

4/#MondayNightIBD #UEGWeek
🆓 #CME🔗http://bit.ly/3XgqsH8

👇#IBDPoll 1️⃣
🟢In the True North open-label extension, the findings indicated that approx 1/2 the pts who failed to achieve a CR after 10wks of ozanimod induction tx benefitted from which of the following:

4/#MondayNightIBD #UEGWeek
🆓 #CME🔗http://bit.ly/3XgqsH8

👇#IBDPoll 1️⃣
🟢In the True North open-label extension, the findings indicated that approx 1/2 the pts who failed to achieve a CR after 10wks of ozanimod induction tx benefitted from which of the following: